PEPTIC ULCER DRUGS MARKET ANALYSIS

Peptic Ulcer Drugs Market, by Product Type (Proton Pump Inhibitors, Potassium-Competitive Acid Blocker (P-CAB), Antacids, H2- Antagonist, Antibiotics, Ulcer Protective) by Disease Indication (Gastitis, Gastric Ulcer, Duodenal Ulcer, Gastroesophageal Reflux Disease (GERD)), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : May 2023
Code : CMI3246
Pages :204
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenges And Opportunities

Global Peptic Ulcer Drugs Market– Market Drivers and Restraints

Side effects associated with peptic ulcer drugs

The major factors that can hamper the growth of the global peptic ulcer drugs market over the forecast period include side effects associated with the drugs used to treat peptic ulcer. Prolonged use of peptic ulcer drugs such as proton pump inhibitors and antibiotics may lead to increased risk of hip bone fracture as the ability to absorb calcium and iron decreases. Other side effects include, risk of opportunistic infections with S. pneumonia and C. defficile, owing to diminished natural gut flora. Such scenario is expected to hamper growth of the global peptic ulcer drugs market.

Market Drivers:Increasing prevalence of peptic ulcers and An increase in the research and development activities are expected to drive market growth.

Market Opportunities include increase in product launches and initiatives by government and non-government organizations.